Is Weed Legal in France?

August 6, 2026

No - weed is illegal in France with a €200 on-the-spot fine for personal use. Medical cannabis is transitioning to prescription status in 2026 under ANSM.

EU Member State

France

Cannabis & Hemp Overview

Last reviewed: August 6, 2026

No — recreational cannabis is illegal in France. Medical cannabis exists only inside a closed, tightly controlled framework that is transitioning from a national experiment to prescription-medicine status. Use of any narcotic, cannabis included, is a criminal offense under Article L.3421-1 of the Code de la santé publique, carrying up to one year's imprisonment and a EUR 3,750 fine — though in practice simple use is handled with a EUR 200 on-the-spot fine. On the medical side, the 2021–2024 experiment run by the ANSM is being converted into a permanent "médicament à base de cannabis" status created by the 2024 Social Security Financing Law, with general prescription access expected late 2026 into 2027.

France Cannabis and Hemp Overview

France is one of Europe's heaviest cannabis-consuming countries and simultaneously one of its strictest prohibition states — a contradiction the government manages with a streamlined fine system rather than reform. There is no decriminalization statute: the amende forfaitaire délictuelle (AFD) that most users receive is a criminal-procedure shortcut, not a civil ticket, and it leaves a record. Meanwhile France runs a large legal hemp industry (it is the EU's biggest hemp producer) and a booming retail CBD sector at or below 0.3% THC — covered in detail on our France CBD legality page. The medical track is the piece in motion: after five years of experimentation, France is standing up a formal prescription framework, but as of August 2026 it remains closed to new patients while the implementing decrees are finalized.

What French Law Actually Says

Article L.3421-1 of the public health code criminalizes use of any classified narcotic: up to one year in prison and EUR 3,750 for simple use. Since September 2020, police have handled most simple-use cases through the AFD — a fixed EUR 200 fine, reduced to EUR 150 if paid within 15 days and raised to EUR 450 if unpaid after 45 days. Paying the AFD extinguishes prosecution but registers the offense. The government has repeatedly moved to raise the fine to EUR 500 — President Macron announced the increase in late 2025 and it is carried in pending security legislation — but as of August 2026 the EUR 200 baseline remains the law in force. Everything beyond simple use escalates sharply under Articles 222-34 to 222-43 of the Code pénal: possession beyond personal-use quantities, transport, cultivation, and sale are trafficking offenses punishable by up to 10 years' imprisonment and fines reaching EUR 7,500,000, with heavier exposure for organized networks.

The Medical Transition: From Experiment to Prescription Medicine

France launched its medical cannabis experiment in March 2021 for five last-resort indications: refractory neuropathic pain, drug-resistant epilepsy, painful spasticity from multiple sclerosis or other central nervous system disorders, resistant oncology symptoms, and palliative care. About 3,000 patients enrolled before intake closed in March 2024, and inhaled flower was withdrawn the same year in favor of oils and capsules. Article 78 of the 2024 Social Security Financing Law then created a permanent status — the médicament à base de cannabis — under which the ANSM grants products a renewable five-year authorization in place of a classic marketing authorization. The rollout has slipped: the implementing decrees on pricing, reimbursement, and the cultivation chain were still in the Conseil d'État pipeline in mid-2026, HAS (health authority) opinions are expected in autumn 2026, and the several hundred patients still being treated from the experiment have had their access extended into 2027 as a bridge. Practical takeaway: hospital-initiated prescriptions for the five indications should open to new patients once the decrees land — late 2026 at the earliest, more realistically 2027.

What This Means for Travelers

There is no legal way to buy marijuana in France — not in Paris, not on the Riviera, not anywhere. Street and social-media sellers are trafficking under the Code pénal, and buyers risk the AFD or worse. Police use the fine aggressively in tourist areas and around transport hubs, and paying on the spot does not make it a parking ticket — it is a recorded criminal-procedure outcome. A foreign medical cannabis card does not authorize you to carry product into France; travelers from another Schengen state carrying a lawfully prescribed cannabis medicine need a Schengen Article 75 certificate from their home authority, and even then flower products invite scrutiny. What is legal is CBD: shops across France sell hemp products at or below 0.3% THC — see our consumer guide to CBD in France before assuming a product is compliant, because HHC and other neo-cannabinoids are banned narcotics.

What This Means for Operators

The near-term French opportunity is pharmaceutical, not retail. Companies wanting into the medical chain need to track the médicament à base de cannabis decrees: authorization will run through ANSM, pricing through category-based reimbursement tiers, and supply through approved cultivation and manufacturing operators — France intends a domestic production chain. The CBD sector operates at or below 0.3% total THC under EU hemp rules, but with active DGCCRF enforcement, a French-language COA expectation, banned neo-cannabinoids (HHC, THCP, H4CBD), and unresolved Novel Food status for ingestibles — our France CBD compliance guide covers the current rulebook. There is no pathway, and no pending bill, for adult-use commerce.

Frequently Asked Questions

Can tourists buy weed legally anywhere in France?
No. There are no coffee shops, dispensaries, or legal sales channels. Every purchase is an illegal transaction, and possession exposes you to the EUR 200 fine or prosecution.

What actually happens if I'm caught with a joint in Paris?
Most likely an on-the-spot amende forfaitaire délictuelle of EUR 200 (EUR 150 if paid within 15 days), plus confiscation. It is a criminal-procedure fine, recorded against you, and refusal or repeat offenses can put you before a prosecutor under Article L.3421-1.

Is CBD legal in France?
Yes. Hemp-derived CBD products at or below 0.3% THC are legal to sell and possess, though HHC and similar synthetic cannabinoids are banned. Our France CBD page covers the details.

Can I bring my medical cannabis into France?
Only with proper paperwork. Schengen residents need an Article 75 certificate covering the trip; travelers from outside Schengen effectively cannot import THC products legally. Arriving with cannabis and only a foreign dispensary receipt is treated as narcotics importation.

Can new patients get medical cannabis in France in 2026?
Not yet. The experiment closed to new enrollment in March 2024, and the permanent prescription framework was still awaiting its implementing decrees as of mid-2026. Existing experiment patients keep access during the transition, which has been extended into 2027.

Will France legalize recreational cannabis?
No. Both recent governments have moved the other way — raising fines and tightening enforcement. No legalization or decriminalization bill is advancing as of August 2026.


This page is provided for informational purposes by ComplyAssistAI LLC and is not legal advice. French narcotics law leaves meaningful discretion to police and courts, and rules change. Travelers and operators should verify current requirements with French counsel. Find one in our Cannabis Lawyer Directory.

France

Cannabis & Hemp Key Facts

Cannabis compliance ai
Legal Status of:  
Cannabis / Marijuana

Illegal

Cannabis compliance ai
Governing Body

ANSM (Agence nationale de sécurité du médicament); Ministère de la Santé; MILDECA

Cannabis compliance ai
Potency/ Product Limits

No consumer THC allowance — any THC product outside the medical framework is a narcotic; hemp/CBD capped at 0.3% total THC

Cannabis compliance ai
Regulating Entity

Code de la santé publique Art. L.3421-1; Code pénal Arts. 222-34 à 222-43; LFSS 2024 Art. 78 (médicaments à base de cannabis)

Import Export Rules for the Country

Cannabis import and export are prohibited outside the licensed pharmaceutical chain. Importing THC products — even with a foreign medical prescription — is narcotics importation under the Code pénal; Schengen travelers carrying lawfully prescribed cannabis medicines need an Article 75 certificate from their home authority. Hemp and CBD products at or below 0.3% total THC may move under EU rules with French-language compliance documentation, while banned neo-cannabinoids such as HHC are treated as narcotics at the border. Medical-framework imports are handled by ANSM-authorized operators pending the domestic cultivation chain.

Locations Cannabis / Hemp Legal FAQ's:

Locations Cannabis / Hemp Legal FAQ's: